745TiPPHASE IB/II, MULTICENTER, SINGLE-ARM TRIAL OF THE ORAL C-MET INHIBITOR MSC2156119J AS MONOTHERAPY IN PATIENTS WITH MET-POSITIVE ADVANCED HEPATOCELLULAR CARCINOMA WITH CHILD-PUGH CLASS A LIVER FUNCTION WHO FAILED SORAFENIB TREATMENT
Faivre, S., Sarholz, B., Johne, A., Zheng, H., Raymond, E.Volume:
25
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdu334.130
Date:
September, 2014
File:
PDF, 64 KB
2014